Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the record history, replacing the previous v3.6.2. This updates the page's revision metadata without altering the study data.SummaryDifference0.1%

- Check17 days agoChange DetectedA new history entry (Version 35) with a Study Status update and revision v3.6.2 was added to the study record on 2026-06-24, and the older revision v3.6.0 was removed on 2026-06-10.SummaryDifference0.3%

- Check31 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has closed for this study. This update is logged under Revision: v3.6.0 on 2026-06-10.SummaryDifference1%

- Check38 days agoChange DetectedThe history page displays a new site revision label, v3.5.5, replacing the previous v3.5.4, indicating an underlying platform update.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision tag (v3.5.4) was added to the study history, replacing the previous v3.5.3 tag. This reflects an administrative update to the record history.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov record history interface.SummaryDifference0.1%

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.